Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

Share Price is delayed by 15 minutes
Get Live Data
8.00    0.875 (12.28%)
Bid:
7.50
Ask:
8.50
Spread: 1.00 (13.333%)
Market Cap: £9.56m
MAC Live PriceLast checked at - London Stock Exchange

Intraday Marechale Cap. Share Chart

Director Dealing

Today 13:30

Marechale Capital Plc - Director Dealing

Marechale Capital Plc - Director Dealing

PR Newswire

LONDON, United Kingdom, June 23

23 June 2026

Marechale Capital plc

(“Marechale” or the "Company")

Director Dealing

Marechale Capital plc, an established London based corporate finance advisory business, announces that on 23 June 2026 it was informed that on 23 June 2026, Mr. Chris Kenning, Non-executive Director of the Company had transferred a part of his shareholding, representing 9,146,670 ordinary shares in the Company, to 1Edge Insurance PCC Limited ("1Edge"), a private company indirectly controlled by Mr. Kenning (the “Transfer”).

Further, to settle a personal tax liability with respect to the Transfer, on 22 June 2026 Mr. Kenning sold 3,000,000 ordinary shares in the Company.

Mr. Kenning remains fully committed to the Company's strategic growth and continues in his role as a Non-executive Director.

Details of the Transfer and the sale of ordinary shares are set out in the Notification of Dealing Form below.

Director/PCA Interest prior to Transfer and sale Number of ordinary shares transferred Number of ordinary shares sold Resultant direct interest in ordinary shares in the Company Resultant direct percentage of voting rights in the Company
Chris Kenning 12,146,670 9, 146,670 3,000,000 - -
1Edge* - - - 9, 146,670 3.56%
*1Edge Insurance PCC Limited is 100 per cent. owned by Stubben Edge Group Limited, whose largest shareholder and regulated controller is Mr. Kenning

Following the above Transfer and sale, the aggregate interest of Mr. Kenning, including the ordinary shares held by 1Edge, is 9,146,670 ordinary shares in the Company, representing approximately 3.56 per cent. of the Company’s enlarged issued share capital, as noted in the announcement 22 June 2026.

Mr. Kenning also has an interest in 250,000 options over ordinary shares in the Company.

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ('MAR'). Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.

The Directors of the Company take responsibility for this announcement.

Enquiries

Marechale Capital

Patrick Booth-Clibborn / Mark Warde-Norbury

Tel: +44 (0)20 7628 5582

Cairn Financial Advisers LLP

(Nominated Adviser)

Jo Turner / Sandy Jamieson

Tel: +44 (0)20 7213 0880

Vigo Consulting

(Financial Public Relations)

Jeremy Garcia / Joe Quinlan

marechale@vigoconsulting.com

Tel: +44 (0)20 7390 0230

Forward looking statement disclaimer

Certain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements.

The Company cautions shareholders and prospective shareholders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances, or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority.

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person closely associated
a. Name Chris Kenning 1Edge Insurance PCC Limited (“1Edge”)
2 Reason for notification
a. Position/Status Non-executive Director PCA of Chris Kenning, Non-executive Director
b. Initial notification/ Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a. Name Marechale Capital plc
b. LEI 2138003NUK6SXCDIAT89
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a. Description of the financial instrument, type of instrumentIdentification Code Ordinary Shares ISIN: GB0005401087
b. Nature of the transaction Transfer / receipt of ordinary shares Sale of ordinary shares
c. Price(s) and volume(s): Price(s) per share (p) Volume(s)

Chris Kenning

1) N/A

2) 8.3p

1Edge

1) N/A

Chris Kenning

1) 9,146,670 (Transfer of shares)

2) 3,000,000

1Edge

1) 9,146,670 (Receipt of shares)

d. Aggregated information Volume Price Volume Price Transfer / receipt of shares

9,146,670

N/A

Sale of shares

3,000,000

8.3p

e. Date of the transaction 23/06/2026 22/06/2026
f. Place of the transaction Outside a trading venue AIM


Date   Source Headline
24th Nov 20207:00 amPRNHalf-year Report
26th Oct 20201:16 pmPRNResult of AGM
2nd Oct 20207:00 amRNSChange of Adviser
28th Sep 20201:20 pmRNSPosting of Annual Report and Notice of AGM
25th Aug 202010:39 amRNSHolding(s) in Company
24th Aug 20207:00 amRNSFinal Results
10th Aug 202010:03 amRNSHolding(s) in Company
7th Aug 20201:05 pmRNSHolding(s) in Company
6th Aug 202010:09 amRNSHolding(s) in Company
5th Aug 202011:35 amRNSHolding(s) in Company
4th Aug 20201:03 pmRNSHolding(s) in Company
30th Jul 20204:40 pmRNSSecond Price Monitoring Extn
30th Jul 20204:35 pmRNSPrice Monitoring Extension
17th Jan 20203:31 pmRNSHolding(s) in Company
12th Dec 20193:08 pmRNSHalf-year Report
24th Sep 201912:16 pmRNSHolding(s) in Company
23rd Sep 20193:38 pmRNSResult of AGM
2nd Sep 20192:46 pmRNSPosting of Annual Report and Notice of AGM
29th Aug 20193:48 pmRNSFinal Results
12th Jul 20191:45 pmRNSBoard Change
1st May 201912:39 pmRNSTrading Statement
25th Jan 201910:16 amRNSInterim Results
12th Dec 20187:00 amRNSChange of Adviser
28th Nov 20185:18 pmRNSChange of Adviser
8th Nov 20183:16 pmRNSDirector/PDMR Shareholding
4th Oct 20182:11 pmRNSResult of AGM
13th Sep 20189:50 amRNSPosting of Annual Report and Notice of AGM
21st Aug 20186:13 pmRNSHolding(s) in Company
21st Aug 201811:35 amRNSFinal Results
5th Jul 20181:55 pmRNSHolding(s) in Company
16th Apr 20182:04 pmRNSHolding(s) in Company
7th Mar 20182:19 pmRNSDirector/PDMR Shareholding
29th Jan 20187:00 amRNSInterim Results
25th Jan 20182:25 pmRNSHolding(s) in Company
8th Dec 201712:01 pmRNSHolding(s) in Company
9th Nov 20175:01 pmRNSTrading Update
14th Sep 201710:57 amRNSResult of AGM
18th Aug 20173:59 pmRNSPosting of Annual Report and Notice of AGM
14th Aug 201712:20 pmRNSDirector/PDMR Shareholding
27th Jul 20177:00 amRNSFinal Results
25th Jan 20171:50 pmRNSCapital reduction update
22nd Dec 201611:37 amRNSDirector/PDMR Shareholding
16th Dec 20167:00 amRNSHalf-year Report
15th Sep 20161:13 pmRNSDirector/PDMR Shareholding
14th Sep 201612:54 pmRNSResult of AGM
24th Aug 20164:36 pmRNSPosting of Annual Report & Notice of AGM
25th Jul 20167:00 amRNSFinal Results
4th May 201611:42 amRNSStmnt re Share Price Movement
20th Jan 20163:14 pmRNSDirectorate Change
19th Jan 20161:11 pmRNSStmnt re Share Price Movement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.